TipRanks
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
Hong Kong Market
3692
Hansoh Pharmaceutical Group Company Limited
RESEARCH TOOLSreports
Want to see HK:3692 full AI Analyst Report?

Hansoh Pharmaceutical Group Company Limited (3692) Ratios

9 Followers

Hansoh Pharmaceutical Group Company Limited Ratios

HK:3692's free cash flow for Q2 2026 was ¥0.92. For the 2026 fiscal year, HK:3692's free cash flow was decreased by ¥ and operating cash flow was ¥0.44. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.88 8.09 10.18 4.21 9.86
Quick Ratio
 4.80 7.95 9.94 4.12 9.69
Cash Ratio
 0.55 0.78 8.39 3.27 6.72
Solvency Ratio
 0.80 1.31 1.59 0.50 0.40
Operating Cash Flow Ratio
 0.76 1.53 1.43 0.45 1.05
Short-Term Operating Cash Flow Coverage
 1.58 166.37 94.49 0.74 0.00
Net Current Asset Value
¥ 32.61B¥ 31.03B¥ 24.46B¥ 21.64B¥ 18.48B
Leverage Ratios
Debt-to-Assets Ratio
 0.09 <0.01 <0.01 0.13 0.15
Debt-to-Equity Ratio
 0.11 <0.01 <0.01 0.17 0.19
Debt-to-Capital Ratio
 0.10 <0.01 <0.01 0.14 0.16
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 <0.01 0.16
Financial Leverage Ratio
 1.23 1.13 1.10 1.28 1.32
Debt Service Coverage Ratio
 1.24 109.91 74.94 0.87 44.15
Interest Coverage Ratio
 120.64 1.71K 602.65 42.58 45.94
Debt to Market Cap
 0.02 <0.01 <0.01 0.05 0.06
Interest Debt Per Share
 0.71 0.02 0.02 0.70 0.75
Net Debt to EBITDA
 -0.07 -0.57 -5.26 -4.32 -4.52
Profitability Margins
Gross Profit Margin
90.47%89.89%90.98%89.80%90.73%
EBIT Margin
37.32%35.94%31.83%37.93%27.79%
EBITDA Margin
39.79%38.56%34.89%41.56%31.25%
Operating Profit Margin
37.52%36.04%32.88%28.10%28.47%
Pretax Profit Margin
49.51%43.59%41.48%37.27%31.43%
Net Profit Margin
42.01%36.97%35.66%32.44%27.54%
Continuous Operations Profit Margin
42.01%36.97%35.66%32.44%27.54%
Net Income Per EBT
84.84%84.81%85.97%87.03%87.63%
EBT Per EBIT
131.97%120.96%126.15%132.64%110.38%
Return on Assets (ROA)
14.33%13.92%13.81%9.92%8.61%
Return on Equity (ROE)
18.26%15.70%15.24%12.71%11.41%
Return on Capital Employed (ROCE)
15.65%15.25%13.92%10.85%9.76%
Return on Invested Capital (ROIC)
11.99%12.91%11.94%8.13%8.54%
Return on Tangible Assets
14.48%14.05%13.92%9.97%8.62%
Earnings Yield
4.10%2.87%4.54%3.66%3.33%
Efficiency Ratios
Receivables Turnover
 5.04 4.91 3.84 3.13 2.62
Payables Turnover
 4.02 4.54 5.07 6.29 3.91
Inventory Turnover
 2.21 2.49 1.70 1.79 1.94
Fixed Asset Turnover
 4.76 4.68 3.78 3.08 2.69
Asset Turnover
 0.34 0.38 0.39 0.31 0.31
Working Capital Turnover Ratio
 0.50 0.54 0.52 0.45 0.43
Cash Conversion Cycle
 146.94 140.37 238.14 262.49 233.83
Days of Sales Outstanding
 72.45 74.36 95.05 116.61 139.21
Days of Inventory Outstanding
 165.21 146.36 215.03 203.87 187.87
Days of Payables Outstanding
 90.72 80.35 71.93 57.98 93.24
Operating Cycle
 237.66 220.72 310.08 320.48 327.08
Cash Flow Ratios
Operating Cash Flow Per Share
 1.07 1.13 0.65 0.50 0.46
Free Cash Flow Per Share
 1.00 1.04 0.61 0.46 0.42
CapEx Per Share
 0.07 0.08 0.04 0.04 0.05
Free Cash Flow to Operating Cash Flow
 0.93 0.93 0.94 0.93 0.90
Dividend Paid and CapEx Coverage Ratio
 2.65 2.69 1.86 3.58 2.78
Capital Expenditure Coverage Ratio
 14.95 13.77 17.40 14.19 10.05
Operating Cash Flow Coverage Ratio
 1.53 64.09 32.76 0.72 0.63
Operating Cash Flow to Sales Ratio
 0.41 0.45 0.32 0.31 0.29
Free Cash Flow Yield
3.71%3.22%3.78%3.23%3.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 24.99 34.85 22.01 27.33 30.00
Price-to-Sales (P/S) Ratio
 10.48 12.90 7.85 8.86 8.26
Price-to-Book (P/B) Ratio
 4.41 5.48 3.36 3.47 3.42
Price-to-Free Cash Flow (P/FCF) Ratio
 27.54 31.01 26.44 30.92 31.40
Price-to-Operating Cash Flow Ratio
 25.67 28.76 24.92 28.74 28.28
Price-to-Earnings Growth (PEG) Ratio
 0.70 1.36 0.46 2.00 -6.90
Enterprise Value Multiple
 26.28 32.88 17.24 17.01 21.93
Enterprise Value
 162.67B 190.49B 73.74B 71.43B 64.28B
EV to EBITDA
 25.72 32.88 17.24 17.01 21.93
EV to Sales
 10.23 12.68 6.01 7.07 6.85
EV to Free Cash Flow
 26.88 30.48 20.26 24.66 26.04
EV to Operating Cash Flow
 25.08 28.27 19.09 22.92 23.45
Tangible Book Value Per Share
 6.16 5.86 4.79 4.08 3.82
Shareholders’ Equity Per Share
 6.23 5.92 4.84 4.11 3.83
Tax and Other Ratios
Effective Tax Rate
 0.15 0.15 0.14 0.13 0.12
Revenue Per Share
 2.62 2.51 2.07 1.61 1.59
Net Income Per Share
 1.10 0.93 0.74 0.52 0.44
Tax Burden
 0.85 0.85 0.86 0.87 0.88
Interest Burden
 1.33 1.21 1.30 0.98 1.13
Research & Development to Revenue
 0.23 0.22 0.22 0.21 0.18
SG&A to Revenue
 0.30 0.32 0.37 0.07 0.06
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.01 0.02 0.02
Income Quality
 0.85 1.03 0.88 0.95 1.06
Currency in CNY